BIOSPECIFICS TECHNOLOGIES CORP
10QSB, EX-27, 2000-12-15
PHARMACEUTICAL PREPARATIONS
Previous: BIOSPECIFICS TECHNOLOGIES CORP, 10QSB, 2000-12-15
Next: MEDWAVE INC, 10-Q, 2000-12-15



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                                 JAN-31-2001
<PERIOD-START>                                    FEB-01-1999
<PERIOD-END>                                      OCT-31-2000
<CASH>                                              1,677,702
<SECURITIES>                                          526,720
<RECEIVABLES>                                         892,752
<ALLOWANCES>                                                0
<INVENTORY>                                         2,021,453
<CURRENT-ASSETS>                                      761,206
<PP&E>                                              5,376,549
<DEPRECIATION>                                      1,413,497
<TOTAL-ASSETS>                                     10,175,332
<CURRENT-LIABILITIES>                                       0
<BONDS>                                                     0
                                       0
                                                 0
<COMMON>                                                4,891
<OTHER-SE>                                         10,835,857
<TOTAL-LIABILITY-AND-EQUITY>                       10,175,332
<SALES>                                             4,076,242
<TOTAL-REVENUES>                                    4,076,242
<CGS>                                               1,584,062
<TOTAL-COSTS>                                       1,584,062
<OTHER-EXPENSES>                                    1,028,757
<LOSS-PROVISION>                                    1,028,757
<INTEREST-EXPENSE>                                      3,797
<INCOME-PRETAX>                                      (852,025)
<INCOME-TAX>                                          (95,000)
<INCOME-CONTINUING>                                  (742,825)
<DISCONTINUED>                                              0
<EXTRAORDINARY>                                             0
<CHANGES>                                                   0
<NET-INCOME>                                                0
<EPS-BASIC>                                             (0.16)
<EPS-DILUTED>                                           (0.16)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission